Skip to main content
CTOS 2025 Main banner
Final Program


Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Samuel Abbou, MD

Children and Adolescent Cancer Department
Gustave Roussy
Paris, Ile-de-France, France

Samuel Abbou is a senior onco-pediatrician (practitioner specializing in cancer centers) in the department of child and adolescent oncology at Gustave Roussy since 2015. He graduated from the Faculty of Medicine of Paris V and was assistant clinical director at the Paris XI faculty of medicine. He continued his training with a degree in pediatric oncology (DIUOP, Université Paris XI), a degree in precision medicine (Université Paris V), a master's 2 in cancerology (Université Paris XI) in the Precision medicine group and innovative therapies (UMR 8203 Vectorology and Anti-cancer Treatments) and in the course of a Doctorate of Science (School of Cancer Sciences, University of Paris XI). Samuel is a member of the French Society for Childhood Cancers (SFCE).

Clinical research
Samuel Abbou devotes a large part of his clinical research activity to early phase trials and is the principal coordinating investigator of the early phase CA309-744 trial. He actively participates in the MAPPYACTS precision program . Samuel is also involved in the management of lymphomas and is the principal coordinating investigator of the Euronet-PHLC2 trial and the Euronet PHLP1 trial.

Basic and translational research
Samuel Abbou works in the "Precision medicine and innovative therapies" group of the CNRS UMR 8203 laboratory, which explores the anomalies involved in oncogenesis and in resistance to treatment in the precision medicine program. His work focuses on liquid biopsy technologies in sarcomas: analysis of circulating tumor DNA for prognostic, therapeutic and understanding of the biology of rhabdomyosarcomas; genomic analysis of circulating osteosarcoma and translocation sarcoma tumor cells. He is currently working in Brian Crompton's sarcoma genomics laboratory at the Dana Farber Cancer Institute / Harvard Medical School in Boston, USA, in collaboration with Gustave Roussy.

Presentation(s):

Email Samuel